The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
The development of RAPTA compounds for the treatment of tumors
Open accessAbstract
Ruthenium(II)-arene RAPTA-type compounds have been extensively explored for their medicinal properties. Herein a comprehensive review of this class of compounds is provided. A discussion of the basic RAPTA structure is given together with the ways it has been modified to elucidate the key role of each part and to afford targeted derivatives. The various mechanistic studies conducted on RAPTA compounds are described and these are linked to the observed macroscopic biological properties. Ultimately, the review shows that certain RAPTA compounds display quite unique properties that point towards a clinical investigation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
Maeda, H., Wu, J., Sawa, T., Matsumura, Y., & Hori, K. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00248-5 · Cited by 6,565
Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems
Tacar, O., Sriamornsak, P., & Dass, C. R. (2013) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.2012.01567.x · Cited by 2,465
Polycyclic aromatic hydrocarbons physically intercalate into duplex regions of denatured DNA
Wolfe, A., Shimer, G. H., & Meehan, T. (1987) · Biochemistry · doi:10.1021/bi00394a013 · Cited by 2,049
Structural Basis of the Drug-binding Specificity of Human Serum Albumin
Ghuman, J., Zunszain, P. A., Petitpas, I., Bhattacharya, A. A., Otagiri, M., & Curry, S. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.07.075 · Cited by 1,941
Organometallic Anticancer Compounds
Gasser, G., Ott, I., & Metzler-Nolte, N. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm100020w · Cited by 1,624
Molecular mechanisms of resistance and toxicity associated with platinating agents
Rabik, C. A., & Dolan, M. E. (2007) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2006.09.006 · Cited by 1,564
Kobayashi, H., Watanabe, R., & Choyke, P. L. (2014) · Theranostics · doi:10.7150/thno.7193 · Cited by 996
Bioorganometallic chemistry—from teaching paradigms to medicinal applications
Hartinger, C. G., & Dyson, P. J. (2009) · Chem. Soc. Rev. · doi:10.1039/b707077m · Cited by 985
Self-citationHartinger, C. G., Zorbas-Seifried, S., Jakupec, M. A., Kynast, B., Zorbas, H., & Keppler, B. K. (2006) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2006.02.013 · Cited by 956
Self-citationRademaker-Lakhai, J. M., van den Bongard, D., Pluim, D., Beijnen, J. H., & Schellens, J. H. M. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0746 · Cited by 833
Hartinger, C. G., Jakupec, M. A., Zorbas‐Seifried, S., Groessl, M., Egger, A., Berger, W., Zorbas, H., Dyson, P. J., & Keppler, B. K. (2008) · Chemistry & Biodiversity · doi:10.1002/cbdv.200890195 · Cited by 830
Self-citationInhibition of Cancer Cell Growth by Ruthenium(II) Arene Complexes
Morris, R. E., Aird, R. E., del Socorro Murdoch, P., Chen, H., Cummings, J., Hughes, N. D., Parsons, S., Parkin, A., Boyd, G., Jodrell, D. I., et al. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm010051m · Cited by 787
In Vitro and in Vivo Evaluation of Ruthenium(II)−Arene PTA Complexes
Scolaro, C., Bergamo, A., Brescacín, L., Delfino, R., Cocchietto, M., Laurenczy, G., Geldbach, T. J., Sava, G., & Dyson, P. J. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050015d · Cited by 784
Self-citationGill, M. R., & Thomas, J. A. (2012) · Chemical Society Reviews · doi:10.1039/c2cs15299a · Cited by 747
Targeting and delivery of platinum-based anticancer drugs
Wang, X., & Guo, Z. (2013) · Chem. Soc. Rev. · doi:10.1039/c2cs35259a · Cited by 684
NKP-1339, the first ruthenium-based anticancer drug on the edge to clinical application
Trondl, R., Heffeter, P., Kowol, C. R., Jakupec, M. A., Berger, W., & Keppler, B. K. (2014) · Chem. Sci. · doi:10.1039/c3sc53243g · Cited by 675
Non Platinum Metal Complexes as Anti‐cancer Drugs
Ott, I., & Gust, R. (2007) · Archiv der Pharmazie · doi:10.1002/ardp.200600151 · Cited by 609
Recent developments in ruthenium anticancer drugs
Levina, A., Mitra, A., & Lay, P. A. (2009) · Metallomics · doi:10.1039/b904071d · Cited by 592
Hyperthermia adds to chemotherapy
Issels, R. D. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2008.07.038 · Cited by 545
Lang, K., Davis, L., Wallace, S., Mahesh, M., Cox, D. J., Blackman, M. L., Fox, J. M., & Chin, J. W. (2012) · Journal of the American Chemical Society · doi:10.1021/ja302832g · Cited by 523
Metal-based anticancer chemotherapeutic agents
Muhammad, N., & Guo, Z. (2014) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2014.02.003 · Cited by 515
Allardyce, C. S., Dyson, P. J., Ellis, D. J., & Heath, S. L. (2001) · Chemical Communications · doi:10.1039/b104021a · Cited by 495
Self-citationThe thioredoxin system—From science to clinic
Gromer, S., Urig, S., & Becker, K. (2004) · Medicinal Research Reviews · doi:10.1002/med.10051 · Cited by 479
Habtemariam, A., Melchart, M., Fernández, R., Parsons, S., Oswald, I. D. H., Parkin, A., Fabbiani, F. P. A., Davidson, J. E., Dawson, A., Aird, R. E., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060596m · Cited by 456
Induction, Regulation, Degradation, and Biological Significance of Mammalian Metallothioneins
Miles, A. T., Hawksworth, G. M., Beattie, J. H., & Rodilla, V. (2000) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409230091169168 · Cited by 429
Coordination chemistry of 1,3,5-triaza-7-phosphaadamantane (PTA)
Phillips, A. D., Gonsalvi, L., Romerosa, A., Vizza, F., & Peruzzini, M. (2004) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2004.03.010 · Cited by 414
Leijen, S., Burgers, S. A., Baas, P., Pluim, D., Tibben, M., van Werkhoven, E., Alessio, E., Sava, G., Beijnen, J. H., & Schellens, J. H. M. (2015) · Investigational New Drugs · doi:10.1007/s10637-014-0179-1 · Cited by 374
Increased tight junctional permeability is associated with the development of colon cancer
Soler, A. P. (1999) · Carcinogenesis · doi:10.1093/carcin/20.8.1425 · Cited by 344
Adhireksan, Z., Davey, G. E., Campomanes, P., Groessl, M., Clavel, C. M., Yu, H., Nazarov, A. A., Yeo, C. H. F., Ang, W. H., Dröge, P., et al. (2014) · Nature Communications · doi:10.1038/ncomms4462 · Cited by 297
Self-citationRuthenium complexes can target determinants of tumour malignancy
Bergamo, A., & Sava, G. (2007) · Dalton Transactions · doi:10.1039/b617769g · Cited by 291
Casini, A., Gabbiani, C., Sorrentino, F., Rigobello, M. P., Bindoli, A., Geldbach, T. J., Marrone, A., Re, N., Hartinger, C. G., Dyson, P. J., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm8006678 · Cited by 270
Self-citationTargeted and multifunctional arene ruthenium chemotherapeutics
Smith, G. S., & Therrien, B. (2011) · Dalton Transactions · doi:10.1039/c1dt11007a · Cited by 262
Chatterjee, S., Kundu, S., Bhattacharyya, A., Hartinger, C. G., & Dyson, P. J. (2008) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-008-0400-9 · Cited by 258
Self-citationOrganometallic Ruthenium(II) Arene Compounds with Antiangiogenic Activity
Nowak-Sliwinska, P., van Beijnum, J. R., Casini, A., Nazarov, A. A., Wagnières, G., van den Bergh, H., Dyson, P. J., & Griffioen, A. W. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm2002074 · Cited by 248
Self-citationOncogenic Raf-1 Disrupts Epithelial Tight Junctions via Downregulation of Occludin
Li, D., & Mrsny, R. J. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.148.4.791 · Cited by 233
Pongratz, M., Schluga, P., Jakupec, M. A., Arion, V. B., Hartinger, C. G., Allmaier, G., & Keppler, B. K. (2004) · Journal of Analytical Atomic Spectrometry · doi:10.1039/b309160k · Cited by 206
Self-citationDorcier, A., Ang, W. H., Bolaño, S., Gonsalvi, L., Juillerat-Jeannerat, L., Laurenczy, G., Peruzzini, M., Phillips, A. D., Zanobini, F., & Dyson, P. J. (2006) · Organometallics · doi:10.1021/om060394o · Cited by 203
Self-citationThe Design of Organometallic Ruthenium Arene Anticancer Agents
Dougan, S. J., & Sadler, P. J. (2007) · CHIMIA · doi:10.2533/chimia.2007.704 · Cited by 202
Modulation of the metastatic progression of breast cancer with an organometallic ruthenium compound
Bergamo (1992) · International Journal of Oncology · doi:10.3892/ijo_00000119 · Cited by 202
Pettinari, R., Marchetti, F., Condello, F., Pettinari, C., Lupidi, G., Scopelliti, R., Mukhopadhyay, S., Riedel, T., & Dyson, P. J. (2014) · Organometallics · doi:10.1021/om500317b · Cited by 187
Self-citationRational Design of an Organometallic Glutathione Transferase Inhibitor
Ang, W. H., Parker, L. J., De Luca, A., Juillerat‐Jeanneret, L., Morton, C. J., Lo Bello, M., Parker, M. W., & Dyson, P. J. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200900185 · Cited by 182
Self-citationClinical implications of the mechanism of epidermal growth factor receptor inhibitors
Marshall, J. (2006) · Cancer · doi:10.1002/cncr.22133 · Cited by 175
A Ruthenium Antimetastasis Agent Forms Specific Histone Protein Adducts in the Nucleosome Core
Wu, B., Ong, M. S., Groessl, M., Adhireksan, Z., Hartinger, C. G., Dyson, P. J., & Davey, C. A. (2011) · Chemistry – A European Journal · doi:10.1002/chem.201100298 · Cited by 174
Self-citationNaphthalimide-Tagged Ruthenium–Arene Anticancer Complexes: Combining Coordination with Intercalation
Kilpin, K. J., Clavel, C. M., Edafe, F., & Dyson, P. J. (2012) · Organometallics · doi:10.1021/om3007079 · Cited by 168
Self-citationInfluence of Hydrogen-Bonding Substituents on the Cytotoxicity of RAPTA Compounds
Scolaro, C., Geldbach, T. J., Rochat, S., Dorcier, A., Gossens, C., Bergamo, A., Cocchietto, M., Tavernelli, I., Sava, G., Röthlisberger, U., et al. (2005) · Organometallics · doi:10.1021/om0508841 · Cited by 157
Self-citationHartinger, C. G., Groessl, M., Meier, S. M., Casini, A., & Dyson, P. J. (2013) · Chemical Society Reviews · doi:10.1039/c3cs35532b · Cited by 157
Self-citationMetal-Based Inhibition of Poly(ADP-ribose) Polymerase − The Guardian Angel of DNA
Mendes, F., Groessl, M., Nazarov, A. A., Tsybin, Y. O., Sava, G., Santos, I., Dyson, P. J., & Casini, A. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm2000135 · Cited by 151
Self-citationSpontaneous CO Release from RuII(CO)2–Protein Complexes in Aqueous Solution, Cells, and Mice
Chaves‐Ferreira, M., Albuquerque, I. S., Matak‐Vinković, D., Coelho, A. C., Carvalho, S. M., Saraiva, L. M., Romão, C. C., & Bernardes, G. J. L. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201409344 · Cited by 144
Babak, M. V., Meier, S. M., Huber, K., Reynisson, J., Legin, A. A., Jakupec, M. A., Roller, A., Stukalov, A., Gridling, M., Bennett, K. L., et al. (2015) · Chemical Science · doi:10.1039/c4sc03905j · Cited by 141
Self-citationRomerosa, A. M., Campos-Malpartida, T., Lidrissi, C., et al. (2006) · Inorganic Chemistry · doi:10.1021/ic051053q · Cited by 135
Systemic Lipoplatin infusion results in preferential tumor uptake in human studies.
Boulikas, T., Stathopoulos, G. P., Volakakis, N., & Vougiouka, M. (2005) · PubMed · Cited by 126
Rapid optimization of drug combinations for the optimal angiostatic treatment of cancer
Weiss, A., Ding, X., B, J. R. V. B., Wong, I., Wong, T. J., Berndsen, R. H., Dormond, O., Dallinga, M. G., Shen, L., Schlingemann, R. O., et al. (2015) · Angiogenesis · doi:10.1007/s10456-015-9462-9 · Cited by 124
Self-citationPreparation, characterization and properties in vitro and in vivo of a paclitaxel–albumin conjugate
Dosio, F., Brusa, P., Crosasso, P., Arpicco, S., & Cattel, L. (1997) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)01656-8 · Cited by 116
Polymers with platinum drugs and other macromolecular metal complexes for cancer treatment
Callari, M., Aldrich-Wright, J. R., de Souza, P. L., & Stenzel, M. H. (2014) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2014.05.002 · Cited by 116
Groessl, M., Terenghi, M., Casini, A., Elviri, L., Łobiński, R., & Dyson, P. J. (2010) · Journal of Analytical Atomic Spectrometry · doi:10.1039/b922701f · Cited by 107
Self-citationGroessl, M., Tsybin, Y. O., Hartinger, C. G., Keppler, B. K., & Dyson, P. J. (2010) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-010-0635-0 · Cited by 106
Self-citationDNA Structural Distortions Induced by Ruthenium−Arene Anticancer Compounds
Gossens, C., Tavernelli, I., & Röthlisberger, U. (2008) · Journal of the American Chemical Society · doi:10.1021/ja800194a · Cited by 99
Water-soluble arene ruthenium complexes: From serendipity to catalysis and drug design
Süß‐Fink, G. (2013) · Journal of Organometallic Chemistry · doi:10.1016/j.jorganchem.2013.07.039 · Cited by 97
Casini, A., Gabbiani, C., Mastrobuoni, G., Luigi Messori, A., Moneti, G., & Pieraccini, G. (2006) · ChemMedChem · doi:10.1002/cmdc.200500079 · Cited by 96
Hanif, M., Nazarov, A. A., Legin, A. A., Groessl, M., Arion, V. B., Jakupec, M. A., Tsybin, Y. O., Dyson, P. J., Keppler, B. K., & Hartinger, C. G. (2011) · Chemical Communications · doi:10.1039/c1cc14713g · Cited by 93
Self-citationHartinger, C. G., Phillips, A. D., & Nazarov, A. A. (2011) · Current Topics in Medicinal Chemistry · doi:10.2174/156802611798040769 · Cited by 91
Self-citationSeršen, S., Kljun, J., Kryeziu, K., Panchuk, R. R., Alte, B., Körner, W., Heffeter, P., Berger, W., & Turel, I. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00288 · Cited by 87
Knipp, M., Karotki, A. V., Chesnov, S., Natile, G., Sadler, P. J., Brabec, V., & Vašák, M. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm070271l · Cited by 85
Nazarov, A. A., Meier, S. M., Zava, O., Nosova, Y. N., Milaeva, E. R., Hartinger, C. G., & Dyson, P. J. (2014) · Dalton Transactions · doi:10.1039/c4dt02764g · Cited by 79
Self-citationStucture and function of transferrin
Chung, M.-S. (1984) · Biochemical Education · doi:10.1016/0307-4412(84)90118-3 · Cited by 70
Thermoresponsive organometallic arene ruthenium complexes for tumour targeting
Clavel, C. M., Păunescu, E., Nowak-Sliwinska, P. M., & Dyson, P. J. (2014) · Chemical Science · doi:10.1039/c3sc53185f · Cited by 63
Self-citationCasini, A., Karotki, A. V., Gabbiani, C., Rugi, F., Vašák, M., Luigi Messori, A., & Dyson, P. J. (2009) · Metallomics · doi:10.1039/b909185h · Cited by 63
Self-citationWolters, D. A., Stefanopoulou, M., Dyson, P. J., & Groessl, M. (2012) · Metallomics · doi:10.1039/c2mt20070h · Cited by 62
Self-citationNazarov, A. A., Risse, J., Ang, W. H., Schmitt, F., Zava, O., Ruggi, A., Groessl, M., Scopelitti, R., Juillerat‐Jeanneret, L., Hartinger, C. G., et al. (2012) · Inorganic Chemistry · doi:10.1021/ic202530j · Cited by 59
Self-citationA bifunctional organometallic ruthenium drug with multiple modes of inducing apoptosis
Chatterjee, S., Biondi, I., Dyson, P. J., & Bhattacharyya, A. (2011) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-011-0772-0 · Cited by 49
Self-citationBlunden, B. M., Lu, H., & Stenzel, M. H. (2013) · Biomacromolecules · doi:10.1021/bm4013919 · Cited by 48
Targeting mTOR: Something Old, Something New
Garber, K. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djp034 · Cited by 30
Renfrew, A. K., Egger, A., Scopelliti, R., Hartinger, C. G., & Dyson, P. J. (2010) · Comptes Rendus Chimie · doi:10.1016/j.crci.2010.03.014 · Cited by 16
Self-citationOrganoruthenium Antagonists of Human A3 Adenosine Receptors
Paira, P., Chow, M. J., Venkatesan, G., Kosaraju, V. K., Cheong, S. L., Klotz, K., Ang, W. H., & Pastorin, G. (2013) · Chemistry - A European Journal · doi:10.1002/chem.201203291 · Cited by 15
Astarina, A., Chow, M. J., & Ang, W. H. (2012) · Australian Journal of Chemistry · doi:10.1071/ch12059 · Cited by 9
Cited by
Recent Strategies to Develop Innovative Photosensitizers for Enhanced Photodynamic Therapy
Pham, T. C., Nguyen, V.-N., Choi, Y., Lee, S., & Yoon, J. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00381 · Cited by 1,813
Zeng, L., Gupta, P., Chen, Y., Wang, E., Ji, L., Chao, H., & Chen, Z.-S. (2017) · Chemical Society Reviews · doi:10.1039/c7cs00195a · Cited by 1,017
Metal-based drugs that break the rules
Allardyce, C. S., & Dyson, P. J. (2016) · Dalton Transactions · doi:10.1039/c5dt03919c · Cited by 308
Self-citation
Metadata
- Authors
- Murray, B. S., Babak, M. V., Hartinger, C. G., & Dyson, P. J.
- Venue
- Coordination Chemistry Reviews
- Publisher
- Elsevier BV
- Published
- 2016-01
- Volume
- 306
- Pages
- 86-114
- ISSN
- 0010-8545 (ISSN-L)
- OpenAlex
- W1178498256
- Cited by
- 455
- References
- 75
- FWCI
- 19.11
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.